Skip to main content

Table 4 Mean and Range T1 (Baseline). T2 (1 week after) and T3 (5 week after); Mean Differences. t-distribution. and p values of T1 - T2 and T1- T3 for within-group change scores in Patient-Reported Outcomes

From: Effect of neuromuscular taping on musculoskeletal disorders secondary to the use of aromatase inhibitors in breast cancer survivors: a pragmatic randomised clinical trial

Self-Reported Outcomes

Experimental

Control

T1

T2

T3

Mean differences

T1 - T2

t (p) value

T1 - T2

Mean differences

T1 - T3

t (p) value

T1 - T3

T1

T2

T3

Mean differences

T1 - T2

t (p) value

T1 - T2

Mean differences

T1 - T3

t (p) value

T1 - T3

POMS

 Tension/Anxiety

9.85 (0–17)

6.05 (−4–17)

5.40 (−4–17)

3.80

3.98 (0.001)

4.45

4.45 (0.00)

7.00 (−2–24)

6.5 (−3–20)

6.5 (− 2–19)

0.50

0.45 (0.65)

0.5

0.63 (0.53)

 Depression/Dejection

12.90 (0–40)

8 (0–31)

6.35 (0–24)

4.90

3.54 (0.002)

6.55

3.90 (0.001)

9.10 (0–36)

10.05 (0–33)

9.3 (0–33)

−0.95

−0.62 (0.54)

− 0.2

− 0.13 (0.89)

 Anger/Hostility

9.50 (0–26)

5.40 (0–15)

4.25 (1–12)

4.10

3.2 (0.005)

5.25

3.63 (0.002)

8.65 (0–25)

5.75 (0–28)

6.6 (0–28)

2.90

2.05 (0.05)

2.05

1.54 (0.13)

 Vigor/Activity

24.40 (10–42)

24.80 (9–43)

28.10 (10–43)

−0.4

−0.28 (0.78)

−3.70

−2.98 (0.008)

28.75 (17–43)

26.70 (11–40)

25.9 (11–40)

2.05

1.91 (0.07)

2.85

2.18 (0.04)

 Fatigue/Inertia

11.75 (2–21)

8.85 (0–21)

6.40 (0–15)

2.90

2.86 (0.01)

5.35

4.42 (0.00)

9.20 (2–16)

8.75 (2–16)

8.00 (0–18)

0.45

0.56 (0.57)

1.20

1.45 (0.16)

 Confusion/Bewilderment

8.6 (0–23)

5.95 (−2–19)

3.75 (−3–17)

2.65

2.80 (0.01)

4.85

4.50 (0.00)

6.55 (−3–24)

7.10 (−2–24)

5.00 (− 2–24)

− 0.55

− 0.72 (0.47)

1.55

1.38 (0.18)

 TMD

128.20 (84–189)

109.90 (80–166)

98.05 (68–153)

18.30

3.45 (0.003)

30.15

5.97 (0.00)

111.75 (67–193)

111.30 (68–194)

109.4 (63–194)

0.45

0.11 (0.90)

2.35

0.53 (0.59)

EORTC QLQ-C30

 Global health status/QoL

53.76 (0–83.33)

67.49 (4–83.33)

76.66 (50–100)

−13.75

−3.62 (0.002)

−22.91

−4.18 (0.00)

57.08 (0–83.33)

63.74 (33.33–91.66)

62.91 (33.33–83.33)

−6.66

− 1.39 (0.18)

− 5.83

− 1.16 (0.25)

Functional scales

 Physical functioning

67.61 (0–100)

78.68 (27–100)

80.18 (20–100)

−11.06

−2.41 (0.26)

− 12.56

− 2.75 (0.01)

76.91 (33.33–100)

74.03 (27–100)

75.03 (27–100)

2.88

0.96 (0.34)

1.88

0.82 (0.41)

 Role functioning

75.83 (0–100)

85.83 (0–100)

91.66 (33.33–100)

−10

−2.34 (0.03)

− 15.83

−3.22 (0.004)

79.16 (0–100)

70.83 (0–100)

79.16 (33–100)

8.33

1.20 (0.24)

0.001

0.00 (1.00)

 Emotional functioning

72.56 (16.66–100)

83.78 (50–100)

85.90 (50–100)

−11.21

−2.95 (0.008)

−13.33

−2.53 (0.02)

79.68 (25–100)

77.96 (25–100)

81.36 (33.33–100)

1.71

0.39 (0.69)

−1.68

−0.38 (0.70)

 Cognitive functioning

81.66 (16.66–100)

91.66 (16.66–100)

92.49 (33.33–100)

−10

−1.98 (0.62)

− 10.83

−2.66 (0.01)

79.99 (16.66–100)

84.99 (0–100)

84.16 (16.66–100)

−5.00

−1.37 (0.18)

−4.16

− 0.72 (0.48)

 Social functioning

79.99 (0–100)

87.49 (0–100)

91.66 (33.33–100)

−7.50

−1.69 (0.10)

− 11.66

−2.40 (0.02)

90.83 (50–100)

86.66 (0–100)

94.99 (66.66–100)

4.16

0.62 (0.54)

−4.16

−0.81 (0.42)

Symptoms scales

 Fatigue

51.07 (11–88.66)

26.62 (11–77.66)

21.62 (0–77.66)

24.45

5.66 (0.00)

29.44

7.25 (0.00)

40.53 (0–77.77)

37.76 (0–77.77)

39.42 (0–77.77)

2.76

0.75 (0.46)

1.10

0.26 (0.79)

 Nausea and vomiting

0.87 (0–16.66)

0.00

1.75 (0–16.66)

0.87

1.00 (0.33)

−0.87

−0.56 (0.57)

1.66 (0–16.66)

0.83 (0–16.66)

0.00

0.83

1.00 (0.33)

1.66

1.45 (0.16)

 Pain

50.83 (0–100)

29.16 (0–83.33)

19.99 (066.66)

21.66

4.61 (0.00)

30.83

5.80 (0.00)

38.33 (0–83.33)

31.66 (0–66.66)

34.16 (0–66.66)

6.66

1.32 (0.20)

4.16

1.04 (0.30)

 Dyspnoea

6.66 (0–100)

5.00 (0–100)

3.33 (0–66.66)

1.66

1.00 (0.33)

3.33

1.45 (0.16)

8.33 (0–100)

8.33 (0–100)

4.99 (0–66.66)

0.00

0.00 (1.00)

3.33

1.00 (0.33)

 Insomnia

53.33 (0–100)

29.99 (0–100)

23.33 (0–66.66)

23.33

2.89 (0.009)

29.99

4.41 (0.00)

44.99 (0–100)

29.99 (0–100)

23.33 (0–100)

15

2.43 (0.02)

21.66

3.32 (0.004)

 Appetite loss

14.99 (0–100)

11.66 (0–66.66)

11.66 (0–66.66)

3.33

0.69 (0.49)

3.33

0.81 (0.42)

14.99 (0–66.66)

18.33 (0–100)

14.99 (0–66.66)

−3.33

−0.49 (0.62)

0.00

0.00 (1.00)

 Constipation

4.99 (0–66.66)

1.66 (0–33.33)

1.66 (0–33.33)

3.33

1.00 (0.33)

3.33

0.80 (0.42)

8.33 (0–66.66)

9.99 (0–66.66)

6.66 (0–66.66)

−1.66

−0.32 (0.74)

1.66

0.27 (0.78)

 Diarrhoea

11.66 (0–66.66)

8.33 (0–66.66)

3.33 (0–33.33)

3.33

0.62 (0.54)

8.33

1.75 (0.09)

6.66 (0–66.66)

4.99 (0–66.66)

8.33 (0–66.66)

1.66

0.43 (0.66)

−1.66

−0.37 (0.71)

 Financial difficulties

8.33 (0–100)

3.33 (0–66.66)

3.33 (0–66.66)

5.00

1.00 (0.33)

5.00

1.00 (0.33)

14.99 (0–66.66)

8.33 (0–66.66)

4.99 (0–66.66)

6.66

1.45 (0.16)

9.99

1.83 (0.08)

 VAS

7.4 (5–10)

6.1 (4–9)

4.90 (1–8)

1.30

7.93 (0.00)

2.50

8.01 (0.00)

6.65 (4–9)

6.15 (2–9)

6.45 (3–9)

0.50

2.12 (0.47)

0.20

1.16 (0.25)

 SFI

57.40 (8–84)

67.20 (20–84)

66.80 (0–92)

−9.8

−5.24 (0.00)

−9.40

−1.74 (0.09)

56.90 (6–96)

59.80 (44–88)

59.20 (40–84)

−2.90

−0.93 (0.36)

−2.30

−0.65 (0.51)

 ULFI

61.80 (16–84)

72.60 (28–92)

72.40 (0–92)

−10.80

−6.89 (0.00)

−10.60

− 2.05 (0.05)

69.60 (40–100)

72.20 (48–100)

70.60 (48–96)

−2.60

−0.95 (0.35)

−1.00

−0.26 (0.79)

 BAI

0.59 (0.07–1.00)

0.42 (0.13–0.93)

0.33 (0.07–0.93)

0.17

4.01 (0.001)

0.25

4.52 (0.00)

0.42 (0–0.86)

0.44 (0–0.80)

0.40 (0–0.80)

−0.02

−0.90 (0.37)

0.01

0.44 (0.66)

 MBS

0.40 (0.00–1.00)

0.19 (0–0.80)

0.17 (0–0.80)

0.21

3.46 (0.003)

0.23

3.61 (0.002)

0.33 (0–0.80)

0.33 (0–0.80)

0.33 (0–0.80)

0.00

0.00 (1.00)

0.00

0.00 (1.00)

 BADIX

0.53 (0.02–1.00)

0.35 (0.01–0.90)

0.28 (0.02–0.90)

0.18

4.80 (0.00)

0.25

5.59 (0.00)

0.40 (0–0.80)

0.42 (0–0.75)

0.39 (0–0.75)

−0.02

−0.93 (0.36)

0.01

0.49 (0.62)

  1. Abbreviations: POMS Profile of Mood States, TMD Total Emotional Distortion, EORTC QLQ-C30 European Organization for Research and Treatment of Cancer (EORT) Quality of Life Questionnaire QLQ-C30, QoL Quality of Life, VAS Visual Analogue Scale, SFI Spine Functional Index, ULFI Upper Limb Functional Index, BAI Backache Index, MBS Morning Stiffness Score, BADIX Backache Disability Index
Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us